PACIRA BIOSCIENCES, INC. Increase (Decrease) in Accounts Payable
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Accounts Payable of $2.25 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-04
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $3.18M, a 53.72% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$936.00K, a 137.99% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.93M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$12.01M, a 1985.87% decline year-over-year.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2025 was -$5.60M, a 281.52% decline from fiscal 2024.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2024 was $3.08M, a 236.68% increase from fiscal 2023.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2023 was $916.00K, a 85.40% decline from fiscal 2022.
- PACIRA BIOSCIENCES, INC. increase (decrease) in accounts payable for fiscal 2022 was $6.27M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $2.25M 10-Q · filed 2026-08-04 | -$681.00K derived: sum of 3 quarters · filed 2026-08-04 | -$12.69M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$936.00K 10-Q · filed 2026-04-30 | -$3.87M derived: sum of 2 quarters · filed 2026-04-30 | -$15.88M derived: sum of 3 quarters · filed 2026-04-30 | -$9.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$14.94M derived: sum of 2 quarters · filed 2026-02-26 | -$8.06M derived: sum of 3 quarters · filed 2026-08-04 | -$5.60M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$12.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.13M derived: sum of 2 quarters · filed 2026-08-04 | -$2.67M 10-Q · filed 2025-11-06 | -$2.99M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $6.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $9.34M 10-Q · filed 2026-08-04 | $9.02M derived: sum of 3 quarters · filed 2026-08-04 | $9.66M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.46M 10-Q · filed 2026-04-30 | $2.14M derived: sum of 2 quarters · filed 2026-04-30 | $2.78M derived: sum of 3 quarters · filed 2026-04-30 | $12.52M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$325.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $312.00K derived: sum of 2 quarters · filed 2026-02-26 | $10.06M derived: sum of 3 quarters · filed 2026-02-26 | $3.08M 10-K · filed 2026-02-26 |
| 2024-09-30 | $637.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.38M derived: sum of 2 quarters · filed 2025-11-06 | $3.41M 10-Q · filed 2025-11-06 | $2.34M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.77M 10-Q · filed 2025-08-05 | $1.70M derived: sum of 3 quarters · filed 2026-02-26 | -$6.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$6.98M 10-Q · filed 2025-05-08 | -$8.05M derived: sum of 2 quarters · filed 2026-02-26 | -$15.74M derived: sum of 3 quarters · filed 2026-02-26 | -$8.69M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.77M derived: sum of 2 quarters · filed 2026-02-26 | -$1.71M derived: sum of 3 quarters · filed 2026-02-26 | $916.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$7.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$640.00K derived: sum of 2 quarters · filed 2024-11-06 | $1.99M 10-Q · filed 2024-11-06 | $3.58M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $7.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $9.68M 10-Q · filed 2024-07-30 | $11.27M derived: sum of 3 quarters · filed 2025-02-27 | $10.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.63M 10-Q · filed 2024-05-07 | $4.22M derived: sum of 2 quarters · filed 2025-02-27 | $3.64M derived: sum of 3 quarters · filed 2025-02-27 | $2.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.01M derived: sum of 2 quarters · filed 2025-02-27 | $167.00K derived: sum of 3 quarters · filed 2025-02-27 | $6.27M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.42M derived: sum of 2 quarters · filed 2023-11-02 | $4.68M 10-Q · filed 2023-11-02 | -$4.76M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$847.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $5.26M 10-Q · filed 2023-08-02 | -$4.18M derived: sum of 3 quarters · filed 2024-02-29 | -$7.16M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $6.11M 10-Q · filed 2023-05-03 | -$3.33M derived: sum of 2 quarters · filed 2024-02-29 | -$6.31M derived: sum of 3 quarters · filed 2024-02-29 | -$2.81M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$9.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$12.42M derived: sum of 2 quarters · filed 2024-02-29 | -$8.91M derived: sum of 3 quarters · filed 2024-02-29 | -$10.26M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $526.00K derived: sum of 2 quarters · filed 2022-11-03 | -$825.00K 10-Q · filed 2022-11-03 | -$3.02M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.16M 10-Q · filed 2022-08-03 | -$39.00K derived: sum of 3 quarters · filed 2023-02-28 | $2.36M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.35M 10-Q · filed 2022-05-04 | -$3.55M derived: sum of 2 quarters · filed 2023-02-28 | -$1.15M derived: sum of 3 quarters · filed 2023-02-28 | -$7.53M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$2.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $205.00K derived: sum of 2 quarters · filed 2023-02-28 | -$6.18M derived: sum of 3 quarters · filed 2023-02-28 | -$3.31M 10-K · filed 2023-02-28 |
| 2020-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$3.98M derived: sum of 2 quarters · filed 2021-11-03 | -$1.12M 10-Q · filed 2021-11-03 | -$3.77M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$3.52M 10-Q · filed 2021-08-03 | -$6.17M derived: sum of 3 quarters · filed 2022-02-28 | -$4.02M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $2.87M 10-Q · filed 2021-05-04 | $217.00K derived: sum of 2 quarters · filed 2022-02-28 | $2.37M derived: sum of 3 quarters · filed 2022-02-28 | $2.49M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$501.00K derived: sum of 2 quarters · filed 2022-02-28 | -$380.00K derived: sum of 3 quarters · filed 2022-02-28 | -$1.82M 10-K · filed 2022-02-28 |
| 2019-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $2.27M derived: sum of 2 quarters · filed 2020-10-30 | $829.00K 10-Q · filed 2020-10-30 | $1.66M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.32M 10-Q · filed 2020-08-06 | -$494.00K derived: sum of 3 quarters · filed 2021-03-01 | $932.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$1.44M 10-Q · filed 2020-05-07 | -$615.00K derived: sum of 2 quarters · filed 2021-03-01 | $811.00K derived: sum of 3 quarters · filed 2021-03-01 | -$2.12M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $827.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $2.25M derived: sum of 2 quarters · filed 2021-03-01 | -$679.00K derived: sum of 3 quarters · filed 2021-03-01 | -$573.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$1.51M derived: sum of 2 quarters · filed 2019-11-08 | -$1.40M 10-Q · filed 2019-11-08 | $1.41M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$2.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.83M 10-Q · filed 2019-08-08 | -$12.00K derived: sum of 3 quarters · filed 2020-02-21 | $737.00K derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | $106.00K 10-Q · filed 2019-05-02 | $2.92M derived: sum of 2 quarters · filed 2020-02-21 | $3.67M derived: sum of 3 quarters · filed 2020-02-21 | $4.57M derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $3.56M derived: sum of 2 quarters · filed 2020-02-21 | $4.47M derived: sum of 3 quarters · filed 2020-02-21 | $5.71M 10-K · filed 2020-02-21 |
| 2017-09-30 | $749.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.65M derived: sum of 2 quarters · filed 2018-11-01 | $2.90M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $905.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.15M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $1.24M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$350.00K 10-K · filed 2019-02-28 | |||
| 2011-09-30 | -$738.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$778.00K 10-Q · filed 2011-10-31 | ||
| 2011-06-30 | -$40.00K 10-Q · filed 2011-08-11 | |||
| 2010-09-30 | $492.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $262.00K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$230.00K 10-Q · filed 2011-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |